Corton Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,269
| Closed | -$122K | – | 343 |
|
|
2025
Q1 | $122K | Sell |
16,269
-16,068
| -50% | -$121K | 0.4% | 113 |
|
|
2024
Q4 | $243K | Sell |
32,337
-7,154
| -18% | -$53.8K | 0.14% | 191 |
|
|
2024
Q3 | $300K | Buy |
+39,491
| New | +$300K | 0.15% | 189 |
|
|
2023
Q1 | – | Sell |
-11,520
| Closed | -$132K | – | 330 |
|
|
2022
Q4 | $132K | Buy |
+11,520
| New | +$132K | 0.11% | 246 |
|